Clinuvel Pharmaceuticals
CUV.AX
#6575
Rank
HK$3.74 B
Marketcap
HK$74.79
Share price
-2.77%
Change (1 day)
-4.85%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2023: HK$0.23 B

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings (TTM) are HK$0.23 B. In 2023 the company made an earning of HK$0.23 B an increase over its 2022 earnings that were of HK$0.18 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2023

Annual earnings

Year Earnings Change
2023HK$0.23 B27.99%
2022HK$0.18 B23.07%
2021HK$0.15 B113.01%
2020HK$70.56 M-28.83%
2019HK$99.15 M32.76%
2018HK$74.68 M75.41%
2017HK$42.57 M-333.26%
2016-HK$18.26 M-70.84%
2015-HK$62.61 M54.22%
2014-HK$40.6 M-16.25%
2013-HK$48.47 M-37.85%
2012-HK$77.99 M-17.76%
2011-HK$94.82 M24.04%
2010-HK$76.44 M-20.92%
2009-HK$96.66 M-11.54%
2008-HK$0.11 B80.4%
2007-HK$60.57 M-2.46%
2006-HK$62.1 M-5.35%
2005-HK$65.61 M60.55%
2004-HK$40.87 M97.37%
2003-HK$20.71 M50.62%
2002-HK$13.75 M121.22%
2001-HK$6.22 M254.48%
2000-HK$1.76 M